MEK1/2 inhibition by binimetinib is effective as a single agent and potentiates the actions of Venetoclax and ABT-737 under conditions that mimic the chronic lymphocytic leukaemia (CLL) tumour microenvironment
Kyle Crassini, Yandong Shen, William S. Stevenson, Richard Christopherson, Chris Ward, Stephen P. Mulligan, O. Giles Best
Research output: Contribution to journal › Article › peer-review
24Citations
(Scopus)
Fingerprint
Dive into the research topics of 'MEK1/2 inhibition by binimetinib is effective as a single agent and potentiates the actions of Venetoclax and ABT-737 under conditions that mimic the chronic lymphocytic leukaemia (CLL) tumour microenvironment'. Together they form a unique fingerprint.